Close Menu
    What's Hot
    Lane Clark & Peacock

    2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

    March 30, 2026
    Just Group

    Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

    March 30, 2026

    Athora Group Completes Acquisition of Pension Insurance Corporation

    March 30, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      March 25, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

      March 11, 2026

      Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

      March 11, 2026

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      March 25, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    New Paper Suggests Vices, Firearms Knock 1.6 Years Off US Life Expectancy

    Longevity and Mortality Risk Transfer October 9, 2024By Aaron Woolner
    Share
    Twitter LinkedIn Email

    Despite spending $4.5trn a year – or $13,400 a person on healthcare – US life expectancy at birth is 77.6 years, one of the lowest among 38 member states of the Organisation of Economically Developed Nations, according to Narrowing the Gap: The Burden of Alcohol, Drugs, and Firearms on U.S. Life Expectancy, a new paper from The Research and Action Institute at the AAMC (Association of American Medical Colleges). 

    The OECD average life expectancy in 2022 is 80.6, and the US figures are over six years below Japan (84.1). In all, more than 27 OECD member states have a life expectancy at birth greater than 80 years and the handful of countries behind the US include Hungary, the Slovak Republic, and Latvia.  

    Kendal Ogera was lead researcher on the paper, which reported that not only was the US performing worse than its peer group of advanced economy states, but the gap has also widened over the last two years. 

    The paper said that in 2022, there were more than 48,000 firearm-related deaths (more than half were recorded as suicides, according to a soon to be published analysis by the AAMC), close to 108,000 drug-related deaths; and more than 51,000 alcohol-induced deaths.  

    “While these numbers made up a small fraction of the nearly 3.3 million deaths in 2022 in the United States, they disproportionately affected children and younger adults — and, as a result, lowered the U.S. life expectancy at birth. If these deaths were eliminated (and other causes of death remained the same), life expectancy at birth would increase by 1.6 years,” the paper said.  

    The AAMC paper said that alcohol, drugs, and firearms deaths in the US were far higher than other countries, and it consistently led the world for the highest level of gun-related deaths in children and teenagers, which were over 9.5 times the rate of Canada in 2021. 

    The paper says that the issue of firearm related deaths in the US appears to be worsening and is now the leading cause of mortality among people aged one to 19 – previously it was unintentional injuries, a category which includes incidents such as car accidents.  

    The US has also had a long term issue with prescription drug use – in 2017 the opioid crisis was classified as a public health emergency by the US government, a status that remains in place.  

    The AAMC research said drug use – including opioids – was the leading cause of death for Americans aged one to 44 years old. According to the latest data from the World Health Authority drug deaths  stood at 31.8 per 100,000 in the US. 

    This figure was significantly higher than neighbouring Canada (19.2) and over 15 times higher than Spain which recorded just 2.1 deaths per 100,000. Despite Scotland recording the highest level of drug deaths in Europe in 2023, the figure for the UK as a whole was 8.4 per 100,00. 

    According to the paper, drug-related deaths were the single biggest factor in reducing US life expectancy at birth figures. The think tank said that if no drug deaths had occurred the average American could expect to live nearly a year longer. 

    “The United States would add an average of 0.4 years and 0.3 years of life expectancy if firearm-related and alcohol-induced deaths, respectively, were eliminated. Younger Americans would see the greatest opportunity for gaining potential years of life if these causes of death were eliminated, though each age group would be impacted to some degree if deaths due to alcohol, drugs, or firearms were eliminated or reduced,” the paper said.  

    There is a wide disparity in drug deaths across the US with the AAMC research indicating that an elimination of substance-linked mortality could spark an even bigger increase in life expectancy in certain jurisdictions.  

    West Virginia, Delaware and Washington DC would each see a 1.4 year jump in life expectancy if drug deaths were eliminated whereas in New Mexico, Alaska, and South Dakota, eliminating alcohol deaths would result in the greatest increase in life expectancy.  

    “In Louisiana, Mississippi, and New Mexico, residents would see the largest gains in life expectancy by eliminating deaths due to firearms,” said the paper. “Overall, 10 states and the District of Columbia would see a jump of at least two years in life expectancy if deaths due to alcohol, drugs, and firearms did not occur, ranging from 2.0 years in South Carolina to 3.0 years in New Mexico.” 

    There was also a significant disparity between ethnic groups. Taking the US as a whole, American Indian, Alaska Native, Black, White, and Hispanic populations would see the largest increases in life expectancy if alcohol, drug, and firearm-related deaths were eliminated.   

    It would only have a minimal impact on Asian populations and there would be no difference to the life expectancy of Native Hawaiian and other Pacific Islander populations would not see any impact on life expectancy.  

    The study did not look at socioeconomic causes for the differences in life expectancy.  

    The AARC report said that while it was impossible to eliminate deaths linked to drugs, alcohol, and firearms, relatively limited progress would have a material impact on increasing the US life expectancy at birth figures.  

    “Federal and state policies can help decrease these deaths and improve life expectancy for all. Reducing causes of death that disproportionately impact children, and young people is particularly important, since youth death rates have the greatest impact on the nation’s average life expectancy. Even a slight reduction in deaths due to the three causes listed above would bring the United States’ life expectancy at birth closer to the OECD average.” 

    2024 - October Clinical Mortality Mortality Risk Volume 3 Issue 10 - October 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

    March 25, 2026By Mark McCord

    Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

    March 25, 2026By Greg Winterton

    US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

    February 25, 2026By Jamie Tucker and Jack Rosen

    Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

    February 11, 2026By Roger Lawrence
    Latest Issue

    Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

    March 11, 2026

    Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

    March 11, 2026

    Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

    March 11, 2026

    Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

    February 25, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.